|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 117.00 GBX | 0.00% |
|
0.00% | -12.69% |
| 08/06 | SkinBioTherapeutics restates 2025 results amid "fabricated" figures | AN |
| 15/05 | FRP Advisory expects double-digit annual revenue climb | AN |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 11.55x | 2.82x | 0.86x | 1.51x | 5.66x | 6.14x | 4.76% | 38Cr | ||
| 17.99x | 6.29x | 0.03x | 4.1x | 11.32x | 11.67x | 2.25% | 525.56Cr | ||
| 16.55x | - | 1.59x | 1.26x | 11.67x | 13.22x | - | 445.32Cr | ||
| 10.02x | 8.25x | 0.28x | 6.78x | 8.2x | 8.44x | 7.15% | 226.76Cr | ||
| 12.11x | 1.14x | 0.59x | - | - | - | - | 130.71Cr | ||
| 17.37x | 4.16x | 2.05x | 3.56x | 9.53x | 9.32x | 4.46% | 128.91Cr | ||
| 14.6x | 3.56x | 4.16x | - | - | - | 4.49% | 61Cr | ||
| 13.04x | 2.17x | 0.29x | 1.97x | 6.55x | 7.15x | 3.66% | 46Cr | ||
| 13.99x | 3.07x | 1.35x | - | - | - | 5.14% | 45Cr | ||
| 20.56x | 7.64x | 0.35x | - | - | - | 1.07% | 37Cr | ||
| 10.66x | - | 0.09x | - | - | - | - | 27Cr | ||
| 9.71x | 3.16x | 2.13x | - | - | - | 4.93% | 27Cr | ||
| Average | 14.01x | 4.23x | 1.15x | 3.19x | 8.82x | 9.32x | 4.21% | 144.84Cr | |
| Weighted average by Cap. | 15.41x | 5.36x | 0.90x | 3.44x | 10.46x | 11.13x | 3.88% |
- Stock Market
- Stocks
- FRP Stock
- Sector FRP Advisory Group plc
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















